Literature DB >> 18580802

Effect of moyamoya disease on neuropsychological functioning in adults.

Peter Karzmark1, Penelope D Zeifert, Simon Tan, Leslie J Dorfman, Teresa E Bell-Stephens, Gary K Steinberg.   

Abstract

OBJECTIVE: Moyamoya disease is a cerebrovascular disorder characterized by progressive occlusion of vessels comprising the circle of Willis, resulting in formation of collaterals that have a cloudy appearance on angiography. Neuropsychological research on the cognitive effects of the disorder in adults has been limited in scope and generalizability; only a few case studies have been published. The current study was intended to more comprehensively document the nature of cognitive impairment in moyamoya disease by assessing a large number of adult cases with a neuropsychological assessment test battery.
METHODS: Thirty-six adult patients with neurodiagnostically confirmed moyamoya disease were given presurgical neuropsychological assessments.
RESULTS: Mean group performances were within normal limits for all measures assessed. The highest rate of impairment was for measures of executive functioning. The lowest rates occurred with memory and perception measures. Cognitive impairment was present in 11 (31%) of the patients; it was judged to be moderate to severe in four patients (11%). Five patients reported a mild level of depression, and two patients reported a moderate level.
CONCLUSION: The present findings suggest that moyamoya disease diagnosed in adults can impair cognition but that the effect is not as severe as in pediatric cases. Executive functioning is most affected. Memory and, to a large extent, intellect are spared. The current pattern of results suggests brain region-behavior correlations that deserve further study.

Entities:  

Mesh:

Year:  2008        PMID: 18580802     DOI: 10.1227/01.neu.0000325866.29634.4c

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  16 in total

1.  Fluctuating frontal lobe dysfunction in a patient with moyamoya disease.

Authors:  Kee Ook Lee; Kyung-Yul Lee
Journal:  Neurol Sci       Date:  2011-02-03       Impact factor: 3.307

2.  Brain PET Poster Sessions PP01-M01 to PP02-N07.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

3.  Influence of Moyamoya disease on psychopathological abnormality in young males in Korea: analysis of multiphasic personal inventory test.

Authors:  Chang Hyun Oh; Hyeonseon Park; Eunyoung Kim; Dong-Keun Hyun; Joonho Chung
Journal:  Neurol Sci       Date:  2012-08-01       Impact factor: 3.307

4.  Selective neuropsychological impairments and related clinical factors in children with moyamoya disease of the transient ischemic attack type.

Authors:  Yen-Hsuan Hsu; Meng-Fai Kuo; Mau-Sun Hua; Chi-Cheng Yang
Journal:  Childs Nerv Syst       Date:  2013-09-05       Impact factor: 1.475

5.  Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H215O PET.

Authors:  Constantin Roder; Patrick Haas; Monika Fudali; Monika Milian; Ulrike Ernemann; Philipp T Meyer; Marcos Tatagiba; Nadia Khan
Journal:  Neurosurg Rev       Date:  2019-11-14       Impact factor: 3.042

6.  Neuroradiologic correlates of cognitive impairment in adult Moyamoya disease.

Authors:  M A Mogensen; P Karzmark; P D Zeifert; J Rosenberg; M Marks; G K Steinberg; L J Dorfman
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

7.  Fronto-Parietal and White Matter Haemodynamics Predict Cognitive Outcome in Children with Moyamoya Independent of Stroke.

Authors:  Eun Jung Choi; Robyn Westmacott; Fenella J Kirkham; Amanda Robertson; Prakash Muthusami; Manohar Shroff; Mahendranath Moharir; Tricia Williams; Peter Dirks; Daune MacGregor; Mahmoud Slim; Elizabeth Pulcine; Ishvinder Bhathal; Matsanga Leyila Kaseka; Andrea Kassner; William Logan; Gabrielle deVeber; Nomazulu Dlamini
Journal:  Transl Stroke Res       Date:  2022-03-25       Impact factor: 6.800

8.  Moyamoya Disease: a ray of hope from a psychosocial perspective.

Authors:  Ashima Nehra; Harsimarpreet Kaur
Journal:  Ann Neurosci       Date:  2015-04

9.  Preliminary study of neurocognitive dysfunction in adult moyamoya disease and improvement after superficial temporal artery-middle cerebral artery bypass.

Authors:  Hyun Joo Baek; Seung Young Chung; Moon Sun Park; Seong Min Kim; Ki Suk Park; Hee Un Son
Journal:  J Korean Neurosurg Soc       Date:  2014-09-30

10.  Neurocognitive dysfunction in adult moyamoya disease.

Authors:  Joanne R Festa; Lauren R Schwarz; Neil Pliskin; C Munro Cullum; Laura Lacritz; Fady T Charbel; Dana Mathews; Robert M Starke; E Sander Connolly; Randolph S Marshall; Ronald M Lazar
Journal:  J Neurol       Date:  2009-12-24       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.